These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 10764845)

  • 21. Islet dysfunction in non-insulin-dependent diabetes mellitus.
    Kahn SE; Porte D
    Am J Med; 1988 Nov; 85(5A):4-8. PubMed ID: 3057894
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM.
    Boden G
    Diabetes; 1997 Jan; 46(1):3-10. PubMed ID: 8971073
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Islet cell dysfunction in progression to diabetes mellitus.
    Spellman CW
    J Am Osteopath Assoc; 2007 May; 107 Suppl():S1-5. PubMed ID: 17724012
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interactions between insulin resistance and insulin secretion in the development of glucose intolerance.
    Cavaghan MK; Ehrmann DA; Polonsky KS
    J Clin Invest; 2000 Aug; 106(3):329-33. PubMed ID: 10930434
    [No Abstract]   [Full Text] [Related]  

  • 25. Islet function in obese adolescents.
    Giannini C; Caprio S
    Diabetes Obes Metab; 2012 Oct; 14 Suppl 3():40-5. PubMed ID: 22928563
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Contribution of free fatty acids to impairment of insulin secretion and action. mechanism of beta-cell lipotoxicity].
    Girard J
    Med Sci (Paris); 2005 Dec; 21 Spec No():19-25. PubMed ID: 16598900
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevention of type 2 diabetes: insulin resistance and beta-cell function.
    Chiasson JL; Rabasa-Lhoret R
    Diabetes; 2004 Dec; 53 Suppl 3():S34-8. PubMed ID: 15561919
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes.
    Lewis GF; Carpentier A; Adeli K; Giacca A
    Endocr Rev; 2002 Apr; 23(2):201-29. PubMed ID: 11943743
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diabetes and branched-chain amino acids: What is the link?
    Bloomgarden Z
    J Diabetes; 2018 May; 10(5):350-352. PubMed ID: 29369529
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Earlier appearance of impaired insulin secretion than of visceral adiposity in the pathogenesis of NIDDM. 5-Year follow-up of initially nondiabetic Japanese-American men.
    Chen KW; Boyko EJ; Bergstrom RW; Leonetti DL; Newell-Morris L; Wahl PW; Fujimoto WY
    Diabetes Care; 1995 Jun; 18(6):747-53. PubMed ID: 7555498
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Insulin resistance].
    Waldhäusl W
    Acta Med Austriaca; 1992; 19(4):96-100. PubMed ID: 1290322
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [And what about diabetes?].
    Cerasi E
    Bull Acad Natl Med; 2007; 191(4-5):941-3; discussion 943. PubMed ID: 18225448
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Abnormalities in insulin secretion in type 2 diabetes mellitus.
    Guillausseau PJ; Meas T; Virally M; Laloi-Michelin M; Médeau V; Kevorkian JP
    Diabetes Metab; 2008 Feb; 34 Suppl 2():S43-8. PubMed ID: 18640585
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insulin resistance and beta-cell dysfunction as therapeutic targets in type 2 diabetes.
    Evans AJ; Krentz AJ
    Diabetes Obes Metab; 2001 Aug; 3(4):219-29. PubMed ID: 11520301
    [No Abstract]   [Full Text] [Related]  

  • 35. Islet-cell abnormalities in non-insulin-dependent diabetes mellitus.
    Raskin P
    Am J Med; 1985 Aug; 79(2B):2-5. PubMed ID: 3898829
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insulin action and secretion in healthy, glucose tolerant first degree relatives of patients with type 2 diabetes mellitus. Influence of body weight.
    Volk A; Renn W; Overkamp D; Mehnert B; Maerker E; Jacob S; Balletshofer B; Häring HU; Rett K
    Exp Clin Endocrinol Diabetes; 1999; 107(2):140-7. PubMed ID: 10320055
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of free fatty acids (FFA) on glucose metabolism: significance for insulin resistance and type 2 diabetes.
    Boden G
    Exp Clin Endocrinol Diabetes; 2003 May; 111(3):121-4. PubMed ID: 12784183
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Beta cell failure: causes and consequences.
    Kahn SE
    Int J Clin Pract Suppl; 2001 Sep; (123):13-8. PubMed ID: 11594291
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel model of type 2 diabetes mellitus based on obesity induced by high-fat diet in BDF1 mice.
    Karasawa H; Nagata-Goto S; Takaishi K; Kumagae Y
    Metabolism; 2009 Mar; 58(3):296-303. PubMed ID: 19217442
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical importance of insulin secretion and its interaction with insulin resistance in the treatment of type 2 diabetes mellitus and its complications.
    Porte D
    Diabetes Metab Res Rev; 2001; 17(3):181-8. PubMed ID: 11424231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.